Tamoxifen for breast cancer prevention: a framework for clinical decisions.

@article{Cykert2004TamoxifenFB,
  title={Tamoxifen for breast cancer prevention: a framework for clinical decisions.},
  author={Samuel Cykert and Nancy Phifer and Charles Hansen},
  journal={Obstetrics and gynecology},
  year={2004},
  volume={104 3},
  pages={433-42}
}
OBJECTIVE Given the potential side effects and an uncertain survival benefit, decisions about tamoxifen treatment for the primary prevention of breast cancer remain complex. Primary care providers, including gynecologists, will need to counsel patients regarding this form of preventive care. In this report, we update cost-effectiveness calculations for tamoxifen chemoprevention and establish reasonable parameters for clinicians' use. METHODS We performed a cost-effectiveness analysis that… CONTINUE READING